lucanthone hydrochloride has been researched along with Hepatitis C, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, M; El Raziky, M; El-Akel, W; El-Sayed, M; Elsharkawy, A; Esmat, G; Ghoneim, H; Khattab, H | 1 |
| Strickland, GT | 1 |
1 review(s) available for lucanthone hydrochloride and Hepatitis C, Chronic
| Article | Year |
|---|---|
Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.
Topics: Egypt; Hepatitis C, Chronic; Humans; Iatrogenic Disease; Liver Diseases, Parasitic; Schistosomiasis; Schistosomicides | 2006 |
1 other study(ies) available for lucanthone hydrochloride and Hepatitis C, Chronic
| Article | Year |
|---|---|
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Praziquantel; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Schistosomiasis; Schistosomicides; Time Factors; Treatment Outcome | 2013 |